...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Injury >Anticoagulation management in hip fracture patients on warfarin
【24h】

Anticoagulation management in hip fracture patients on warfarin

机译：华法林对髋部骨折患者的抗凝治疗

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

I read with interest the paper from Al-Rashid and Parker. It is an interesting co-incidence that a very similar study has been published almost simultaneously with very similar findings. Both the studies note significant surgical delay in the fracture neck of femur patients because of warfarin anti-coagulation therapy. These studies illustrate the variation in practice, and the lack of guidelines, as only a small proportion of patients received fresh frozen plasma or vitamin K and that too after an initial period of expectant wait for the INR to drop. One of the observations in the study by Bansal and Watson2 which I particularly found interesting, and against the common belief, was the rise in iNR even after the warfarin therapy was stopped, in nearly 50% of their patients.
机译：我感兴趣地阅读了Al-Rashid和Parker的论文。有趣的偶然发现是，几乎同时发表了一项非常相似的研究，并得出了非常相似的发现。两项研究均指出，由于华法林抗凝治疗，导致股骨患者骨折颈部明显延迟手术。这些研究说明了实践中的差异以及缺乏指导原则，因为只有一小部分患者接受了新鲜的冷冻血浆或维生素K，并且在预期的初期等待INR下降之后也是如此。 Bansal和Watson2在研究中发现的一项有趣的发现是，即使在停止使用华法林治疗后，iNR的升高也与我的普遍看法相反，在他们的近50％的患者中，iNR的升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号